Lutein and zeaxanthin supplementation in preterm infants to prevent retinopathy of prematurity: A randomized controlled study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 5, 2012, Pages 523-527

  Dani, Carlo ^a   Lori, Ilaria ^a   Favelli, Federica ^a   Frosini, Saverio ^b   Messner, Hubert ^c   Wanker, Petra ^c   De Marini, Sergio ^d   Oretti, Chiara ^d   Boldrini, Antonio ^e   Ciantelli , Massimiliano ^e   Bragetti, Patrizia ^f   Germini, Cristiana ^f  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Neonatal Intensive Care Unit of Ospedale Regionale   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Lutein; preterm infants; retinopathy of prematurity

Indexed keywords

LUTEINOFTA; PLACEBO; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYE SURGERY; FEMALE; GESTATIONAL AGE; HIGH RISK INFANT; HOSPITAL DISCHARGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; TREATMENT RESPONSE;

EID: 84859902539     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.629252     Document Type: Article

References (32)

1. Drack AV. Preventing blindness in premature infants. N Engl J Med 1998;338:1620-1621. (Pubitemid 28243994)
2. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628-1640.
3. Hardy RJ, Good WV, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B. Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of early treatment for retinopathy of prematurity: Study design. Control Clin Trials 2004;25:311-325. (Pubitemid 38626166)
4. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B. Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15-23.
5. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 2001;62:57-63. (Pubitemid 32178136)
6. Dani C, Martelli E, Bertini G, Pezzati M, Rossetti M, Buonocore G, Paffetti P, Rubaltelli FF. Effect of blood transfusions on oxidative stress in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F408-F411. (Pubitemid 39178816)
7. Tlucek PS, Corff KE, Bright BC, Bedwell SM, Sekar KC, Siatkowski RM. Effect of decreasing target oxygen saturation on retinopathy of prematurity. J AAPOS 2010;14:406-411.
8. Chen ML, Guo L, Smith LE, Dammann CE, Dammann O. High or low oxygen saturation and severe retinopathy of prematurity: A metaanalysis. Pediatrics 2010;125:e1483-e1492.
9. Brooks SE, Marcus DM, Gillis D, Pirie E, Johnson MH, Bhatia J. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics 1999;104:514-518. (Pubitemid 29424673)
10. Phelps DL, Rosenbaum AL, Isenberg SJ, Leake RD, Dorey FJ. Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized, controlled, double-masked trial. Pediatrics 1987;79:489-500. (Pubitemid 17051407)
11. Johnson L, Quinn GE, Abbasi S, Gerdes J, Bowen FW, Bhutani V. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: Incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. J Pediatr 1995;127:632-639.
12. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 2006;82:828-839. (Pubitemid 43170883)
13. McNulty HP, Byun J, Lockwood SF, Jacob RF, Mason RP. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim Biophys Acta 2007;1768:167-174.
14. Moeller SM, Jacques PF, Blumberg JB. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J Am Coll Nutr 2000;19:522-527.
15. Barker FM 2nd. Dietary supplementation: Effects on visual performance and occurrence of AMD and cataracts. Curr Med Res Opin 2010;26:2011-2023.
16. Jewell VC, Northrop-Clewes CA, Tubman R, Thurnham DI. Nutritional factors and visual function in premature infants. Proc Nutr Soc 2001;60:171-178. (Pubitemid 32476014)
17. Minicucci G, Lepore D, Molle F. Abnormal retinal vascularisation in preterm children. Lancet 1999;353:1099-1100. (Pubitemid 29149930)
18. Yeum KJ, Ferland G, Patry J, Russell RM. Relationship of plasma carotenoids, retinol and tocopherols in mothers and newborn infants. J Am Coll Nutr 1998;17:442-447. (Pubitemid 28445333)
19. Bettler J, Zimmer JP, Neuringer M, DeRusso PA. Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur J Nutr 2010;49:45-51.
20. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;124:1669-1670.
21. Watterberg KL. American Academy of Pediatrics. Committee on Fetus and Newborn. Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics 2011;127:575-579.
22. American Academy of Pediatric's Committee on drugs, Committee on fetus and newborn and Committee on Infectious Diseases. Pediatrics 1980;65:1047-1053.
23. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K. National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116:1353-1360.
24. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534. (Pubitemid 8293290)
25. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
26. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res 1992;49:1-6.
27. Zimmer JP, Hammond BR Jr. Possible influences of lutein and zeaxanthin on the developing retina. Clin Ophthalmol 2007;1:25-35.
28. Perrone S, Longini M, Marzocchi B, Picardi A, Bellieni CV, Proietti F, Rodriguez A, et al. Effects of lutein on oxidative stress in the term newborn: A pilot study. Neonatology 2010;97:36-40.
29. Romagnoli C, Tirone C, Persichilli S, Gervasoni J, Zuppi C, Barone G, Zecca E. Lutein absorption in premature infants. Eur J Clin Nutr 2010;64:760-761.
30. Delcourt C, Carrière I, Delage M, Barberger-Gateau P, Schalch W. POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: The POLA Study. Invest Ophthalmol Vis Sci 2006;47:2329-2335. (Pubitemid 351639812)
31. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Max Snodderly D. Nutritional manipulation of primate retinas. IV. Effects of n-3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region. Exp Eye Res 2005;81:513-529. (Pubitemid 41531997)
32. Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004;14:140-144.